cholestyramine resin has been researched along with Osteogenic Sarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horiuchi, R; Shinozaki, T; Takagishi, K; Tomidokoro, R; Watanabe, H; Yamamoto, K | 1 |
Falletta, JM; Moncino, MD | 1 |
Erttmann, R; Gkanatsas, A | 1 |
3 other study(ies) available for cholestyramine resin and Osteogenic Sarcoma
Article | Year |
---|---|
Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
Topics: Anion Exchange Resins; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Cholestyramine Resin; Humans; Kidney; Liver; Male; Methotrexate; Osteosarcoma; Tibia; Time Factors; Treatment Outcome | 2000 |
Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy.
Topics: Adolescent; Agranulocytosis; Bone Neoplasms; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Osteosarcoma; Recurrence; Time Factors | 1992 |
[Clinical significance of non-renal elimination mechanisms of methotrexate (MTX)].
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bile; Child; Child, Preschool; Cholestyramine Resin; Chromatography, High Pressure Liquid; Enterohepatic Circulation; Female; Femoral Neoplasms; Humans; Kinetics; Lymphoma; Male; Metabolic Clearance Rate; Methotrexate; Neoplasms; Osteosarcoma | 1985 |